Sort
39,280 grants matching “leukemia”
Targeting aberrant epigenetics by nanomedicine
$327,444Shujun Liu · University Of Minnesota · R01 · FY2013 · CA
Project 1: HDAC inhibition and GVHD
$327,440Pavan Reddy · Icahn School Of Medicine At Mount Sinai · P01 · FY2020 · CA
Autologous CD19 Targeted 19-28z+ Tcells for the Treatment of Relapsed Diffuse Large B cell Lymphoma in Transplant Ineligible Elderly Patients
$327,436Renier Joseph Brentjens · Sloan-Kettering Inst Can Research · P50 · FY2018 · CA
Gene-Engineered Stem Cell Memory T-Cells With Anti-HIV Chimeric Antigen Receptors
$327,432Masakazu Kamata · University Of Alabama At Birmingham · R01 · FY2019 · AI
Defining the Role of MafA in Islet Beta Cells
$327,425Roland W Stein · Vanderbilt University · R01 · FY2013 · DK
Heme trafficking and its impact on systemic iron homeostasis
$327,425Janis L Abkowitz · University Of Washington · R01 · FY2013 · DK
DEVELOPMENT OF ANTICANCER 1, 2-BIS(SULFONYL) HYDRAZINES
$327,409Yale University · R01 · FY2002 · CA
Cell Cycle Regulation and Leukemogenesis by CBFb-SMMHC
$327,409Johns Hopkins University · R01 · FY2005 · CA
DEVELOPMENT OF ANTICANCER 1, 2-BIS(SULFONYL) HYDRAZINES
$327,409Yale University · R01 · FY2003 · CA
Cell Cycle Regulation and Leukemogenesis by CBFb-SMMHC
$327,409Johns Hopkins University · R01 · FY2003 · CA
Cell Cycle Regulation and Leukemogenesis by CBFb-SMMHC
$327,409Johns Hopkins University · R01 · FY2004 · CA
DEVELOPMENT OF ANTICANCER 1, 2-BIS(SULFONYL) HYDRAZINES
$327,409Yale University · R01 · FY2004 · CA
RNA Tumor Virus-Hematopoietic cell Interaction
$327,350Naomi Rosenberg · Tufts University Boston · R01 · FY2006 · CA
The chromatin response in mammalian double strand break repair
$327,342Ralph Scully · Beth Israel Deaconess Medical Center · R01 · FY2012 · GM
The chromatin response in mammalian double strand break repair
$327,342Ralph Scully · Beth Israel Deaconess Medical Center · R01 · FY2014 · GM
Pharmacogenomics of cytosine arabinoside (Ara-C) and acute myelogenous leukemia
$327,333Richard M Weinshilboum · Mayo Clinic Rochester · R01 · FY2011 · CA
Characterization of a T cell dysfunctional state induced in mice with AML
$327,332Justin P. Kline · University Of Chicago · R01 · FY2012 · CA
Role of autophagy in normal and transformed hematopoietic stem cells
$327,332Emmanuelle Passegue · University Of California, San Francisco · R01 · FY2014 · CA
Genomic biomarkers for cutaneous T-cell Lymphoma
$327,323Megan S. Lim · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Data Compilation Core
$327,307Stephen L George · Univ Of North Carolina Chapel Hill · P01 · FY2013 · CA
Improving Biopsies using Magnetic Nanoparticles
$327,296Edward R Flynn · Senior Scientific · R44 · FY2009 · CA
DISCOVERY OF FIRST-IN-CLASS NSD2 DEGRADERS FOR CANCER THERAPY
$327,284Lindsey Ingerman James · Univ Of North Carolina Chapel Hill · R01 · FY2023 · CA
Project 5: Transplant Conditioning for MDS and AML with Biological Agents
$327,278Judith Anne Shizuru · Stanford University · P01 · FY2021 · CA
Project 5: Transplant Conditioning for MDS and AML with Biological Agents
$327,278Judith Anne Shizuru · Stanford University · P01 · FY2023 · CA
CD 74 Directed Immunotherapy for B Cell Malignancies
$327,262John P Leonard · Weill Medical Coll Of Cornell Univ · R21 · FY2007 · CA